The Recall Desk

Manufacturer

Novo Nordisk Inc.

18 recalls in our database name Novo Nordisk Inc. as the manufacturing or recalling firm.

What the numbers show

Total
18
Critical
1
Severe
10
Most recent
2026-01-07

Of the 18 recalls from Novo Nordisk Inc. we have scored against our rubric, 1 (6%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 10 (56%) are Severe.

Which agencies issued them

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–18 of 18

  • HighFDA (Drugs)·D-0244-2026·2026-01-07

    Wegovy 0.5 mg pens recalled after hair was found in a syringe

    Novo Nordisk is recalling Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL prefilled pens, over the presence of particulate matter after hair was found in a prefilled syringe.

    Product
    Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0245-2026·2026-01-07

    Wegovy prefilled pens recalled after hair was found in a syringe

    Novo Nordisk is recalling Wegovy (semaglutide) Injection, 1 mg/0.5 mL prefilled pens, over the presence of particulate matter after hair was found in a prefilled syringe.

    Product
    Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0614-2021·2021-04-21

    Novo Nordisk Recalls Levemir Insulin Pens Due to Temperature Abuse

    Novo Nordisk is recalling Levemir FlexTouch insulin pens stored below 32°F, which may cause lack of efficacy and damage to the cartridge and pen-injectors.

    Product
    LEVEMIR — LEVEMIR (INSULIN DETEMIR)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0612-2021·2021-04-21

    Novo Nordisk Recalls Fiasp Insulin Due to Temperature Abuse

    Novo Nordisk is recalling Fiasp insulin cartridges stored below 32°F, which may cause lack of efficacy and damage to the cartridge and pen-injectors.

    Product
    FIASP — FIASP (INSULIN ASPART INJECTION)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0616-2021·2021-04-21

    Novo Nordisk Recalls Insulin Diluting Medium Due to Temperature Abuse

    Novo Nordisk Inc is recalling samples of Insulin Diluting Medium for NovoLog because storage below 32°F may cause lack of efficacy and damage to cartridges and pen-injectors.

    Product
    INSULIN DILUTING MEDIUM FOR NOVOLOG — INSULIN DILUTING MEDIUM FOR NOVOLOG (WATER INJECTION)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0611-2021·2021-04-21

    Novo Nordisk Recalls Fiasp Insulin Pens Due to Temperature Abuse

    Novo Nordisk is recalling Fiasp insulin pen samples stored below 32°F. The temperature abuse may cause lack of efficacy and damage to the cartridge and pen-injectors.

    Product
    FIASP — FIASP (INSULIN ASPART INJECTION)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0620-2021·2021-04-21

    Novo Nordisk Recalls TRESIBA Insulin Samples Due to Temperature Abuse

    Novo Nordisk is recalling TRESIBA (insulin degludec) samples stored below 32°F, which may cause lack of efficacy and damage to the cartridge and pen-injectors.

    Product
    TRESIBA — TRESIBA (INSULIN DEGLUDEC)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0621-2021·2021-04-21

    Novo Nordisk Recalls TRESIBA Insulin Pens Due to Temperature Abuse

    Novo Nordisk is recalling specific lots of TRESIBA insulin pens because they were stored below 32°F, which may reduce efficacy and damage the device.

    Product
    TRESIBA — TRESIBA (INSULIN DEGLUDEC)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0619-2021·2021-04-21

    Novo Nordisk Recalls TRESIBA Insulin Pens Due to Temperature Abuse

    Novo Nordisk is recalling TRESIBA (insulin degludec) prefilled pens because they were stored below 32°F, which may reduce efficacy and damage the device.

    Product
    TRESIBA — TRESIBA (INSULIN DEGLUDEC)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0613-2021·2021-04-21

    Novo Nordisk Recalls Fiasp Insulin Samples Due to Temperature Abuse

    Novo Nordisk is recalling Fiasp (insulin aspart injection) samples stored below 32°F, which may cause lack of efficacy and damage to the cartridge and pen-injectors.

    Product
    FIASP — FIASP (INSULIN ASPART INJECTION)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0623-2021·2021-04-21

    Novo Nordisk Recalls Xultophy 100/3.6 Due to Temperature Abuse

    Novo Nordisk is recalling Xultophy 100/3.6 samples stored below 32°F. The temperature abuse may cause lack of efficacy and damage to the cartridge and pen-injectors.

    Product
    XULTOPHY 100/3.6 — XULTOPHY 100/3.6 (INSULIN DEGLUDEC AND LIRAGLUTIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0615-2021·2021-04-21

    Novo Nordisk Recalls Insulin Diluting Medium Due to Temperature Abuse

    Novo Nordisk is recalling specific samples of Insulin Diluting Medium for NovoLog because they were stored below 32°F, potentially causing lack of efficacy and damage to the cartridge and pen-injectors.

    Product
    INSULIN DILUTING MEDIUM FOR NOVOLOG — INSULIN DILUTING MEDIUM FOR NOVOLOG (WATER INJECTION)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0618-2021·2021-04-21

    Novo Nordisk Recalls Saxenda Injection Samples Due to Temperature Abuse

    Novo Nordisk is recalling Saxenda (liraglutide) injection samples that were stored below 32°F. The temperature abuse may cause lack of efficacy and damage to the cartridge and pen-injectors.

    Product
    SAXENDA — SAXENDA (LIRAGLUTIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0617-2021·2021-04-21

    Novo Nordisk Recalls OZEMPIC Injection Pens Due to Temperature Abuse

    Novo Nordisk is recalling OZEMPIC sample pens stored below 32°F, which may cause lack of efficacy and damage to the cartridge and pen-injectors.

    Product
    OZEMPIC (semaglutide) injection, 2 mg/1.5 mL (1.34 mg/mL) Prefilled pen, 1 pen, Sample. Not for Resale, Rx only, Novo Nordisk Inc, Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-4132-90 (Pen), NDC 0169-4132-97 (Kit)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0622-2021·2021-04-21

    Novo Nordisk Recalls Victoza Injection Due to Temperature Abuse

    Novo Nordisk is recalling specific lots of Victoza (liraglutide) injection because they were stored below 32°F, potentially causing loss of efficacy and device damage.

    Product
    VICTOZA — VICTOZA (LIRAGLUTIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Devices)·Z-0206-2018·2017-12-13

    Novo Nordisk Recalls Dial-A-Dose Insulin Pen Cartridge Holders

    Novo Nordisk is recalling specific batches of Dial-A-Dose insulin pen cartridge holders because they may crack or break when exposed to certain cleaning agents.

    Product
    Dial-A-Dose Insulin Delivery Device (Pen-Injector) cartridge holders Product Usage: The NovoPen Echo¿ is a re-usable pen injector for single patient use by diabetics for the self injection of a desired dose of insulin. The pen injector uses Penfill 3 mL cartridge of NovoLog¿,
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0217-2017·2016-12-28

    Novo Nordisk Recalls GlucaGen HypoKits Due to Detached Needles

    Novo Nordisk is recalling 71,215 GlucaGen HypoKits because the syringe needles may be detached. The recall covers lots expiring in September 2017.

    Product
    GlucaGen HypoKit (glucagon [rDNA origin] for injection), 1 mg per vial, Single use only, Rx Only, Manufactured by: Novo Nordisk A/S 2880 Bagsvaerd, Denmark, NDC 0169-7065-15
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0956-2016·2016-06-15

    Novo Nordisk Recalls Norditropin Pens Due to Delivery System Defect

    Novo Nordisk is recalling 723 Norditropin FlexPro pens due to a potential assembly fault that may cause the pen to block during the air shot step.

    Product
    NORDITROPIN — NORDITROPIN (SOMATROPIN)
    Category
    Drug
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Novo Nordisk

Danish pharmaceutical company

Country
Denmark
Founded
1923
Parent company
Novo Holdings

Official website

Source: Wikidata (Q818846), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.